基于十年随访数据的非小细胞肺癌手术切除患者的部位特异性随访策略

IF 4.4 2区 医学 Q1 ONCOLOGY Lung Cancer Pub Date : 2025-03-01 Epub Date: 2025-02-16 DOI:10.1016/j.lungcan.2025.108451
Molin Zhang , Chaoqiang Deng , Fangqiu Fu , Yuan Li , Yang Zhang , Haiquan Chen
{"title":"基于十年随访数据的非小细胞肺癌手术切除患者的部位特异性随访策略","authors":"Molin Zhang ,&nbsp;Chaoqiang Deng ,&nbsp;Fangqiu Fu ,&nbsp;Yuan Li ,&nbsp;Yang Zhang ,&nbsp;Haiquan Chen","doi":"10.1016/j.lungcan.2025.108451","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>There is currently no consensus regarding the optimal site-specific postoperative follow-up duration for patients with completely resected non-small cell lung cancer. Long-term surveillance for recurrence may lead to psychological distress or economic burdens for patients.We aimed to propose an appropriate site-specific follow-up strategy for patients with non-small cell lung cancer based on 10-year follow-up data.</div></div><div><h3>Materials and methods</h3><div>We analyzed recurrence patterns in 2,359 patients with non-small cell lung cancer who underwent surgical resection from 2008 to 2013. We established potential site-specific follow-up endpoints when the subsequent recurrence rates fell below 5% and proposed a corresponding follow-up strategy.</div></div><div><h3>Results</h3><div>With a median follow-up of 111.0 months, postoperative recurrences were observed in 985 patients (41.8 %). We identified several factors associated with site-specific recurrence recurrence patterns, including ground-glass opacity component, sex, histology type, and pathological TNM stage. No recurrence was observed in patients with pure ground-glass nodules, a consolidation-to-tumor ratio less than 0.5, or a pathological type classified as lepidic pattern-predominant adenocarcinoma. In thorax, brain and bone, patients with non-squamous cell carcinoma exhibited higher recurrence rates than those with squamous cell carcinoma. In abdomen and neck, male patients have a higher recurrence rate than female patients, particularly within the pathological stage III group.</div></div><div><h3>Conclusions</h3><div>The follow-up strategy was developed based on the recurrence patterns analyzed from ten-year follow-up data. The online tool may assist in determining the optimal site-specific duration for surveillance based on clinicopathologic features.</div></div>","PeriodicalId":18129,"journal":{"name":"Lung Cancer","volume":"201 ","pages":"Article 108451"},"PeriodicalIF":4.4000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Site-specific follow-up strategy for surgically resected patients with NSCLC based on ten-year follow-up data\",\"authors\":\"Molin Zhang ,&nbsp;Chaoqiang Deng ,&nbsp;Fangqiu Fu ,&nbsp;Yuan Li ,&nbsp;Yang Zhang ,&nbsp;Haiquan Chen\",\"doi\":\"10.1016/j.lungcan.2025.108451\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>There is currently no consensus regarding the optimal site-specific postoperative follow-up duration for patients with completely resected non-small cell lung cancer. Long-term surveillance for recurrence may lead to psychological distress or economic burdens for patients.We aimed to propose an appropriate site-specific follow-up strategy for patients with non-small cell lung cancer based on 10-year follow-up data.</div></div><div><h3>Materials and methods</h3><div>We analyzed recurrence patterns in 2,359 patients with non-small cell lung cancer who underwent surgical resection from 2008 to 2013. We established potential site-specific follow-up endpoints when the subsequent recurrence rates fell below 5% and proposed a corresponding follow-up strategy.</div></div><div><h3>Results</h3><div>With a median follow-up of 111.0 months, postoperative recurrences were observed in 985 patients (41.8 %). We identified several factors associated with site-specific recurrence recurrence patterns, including ground-glass opacity component, sex, histology type, and pathological TNM stage. No recurrence was observed in patients with pure ground-glass nodules, a consolidation-to-tumor ratio less than 0.5, or a pathological type classified as lepidic pattern-predominant adenocarcinoma. In thorax, brain and bone, patients with non-squamous cell carcinoma exhibited higher recurrence rates than those with squamous cell carcinoma. In abdomen and neck, male patients have a higher recurrence rate than female patients, particularly within the pathological stage III group.</div></div><div><h3>Conclusions</h3><div>The follow-up strategy was developed based on the recurrence patterns analyzed from ten-year follow-up data. The online tool may assist in determining the optimal site-specific duration for surveillance based on clinicopathologic features.</div></div>\",\"PeriodicalId\":18129,\"journal\":{\"name\":\"Lung Cancer\",\"volume\":\"201 \",\"pages\":\"Article 108451\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lung Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0169500225000728\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0169500225000728","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:对于完全切除的非小细胞肺癌患者的最佳部位特异性术后随访时间,目前尚无共识。长期监测复发可能给患者带来心理困扰或经济负担。我们的目的是基于10年的随访数据,为非小细胞肺癌患者提出合适的部位特异性随访策略。材料和方法我们分析了2008年至2013年2359例接受手术切除的非小细胞肺癌患者的复发模式。当复发率低于5%时,我们建立了潜在的部位特异性随访终点,并提出了相应的随访策略。结果中位随访111.0个月,术后复发985例(41.8%)。我们确定了与部位特异性复发模式相关的几个因素,包括毛玻璃混浊成分、性别、组织学类型和病理TNM分期。纯磨玻璃结节、实变与肿瘤之比小于0.5或病理类型为鳞状腺癌的患者未见复发。在胸部、脑部和骨骼,非鳞状细胞癌患者的复发率高于鳞状细胞癌患者。在腹部和颈部,男性患者的复发率高于女性患者,尤其是病理III期患者。结论根据10年随访资料分析复发模式,制定随访策略。在线工具可以帮助确定基于临床病理特征的最佳部位特异性监测持续时间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Site-specific follow-up strategy for surgically resected patients with NSCLC based on ten-year follow-up data

Objectives

There is currently no consensus regarding the optimal site-specific postoperative follow-up duration for patients with completely resected non-small cell lung cancer. Long-term surveillance for recurrence may lead to psychological distress or economic burdens for patients.We aimed to propose an appropriate site-specific follow-up strategy for patients with non-small cell lung cancer based on 10-year follow-up data.

Materials and methods

We analyzed recurrence patterns in 2,359 patients with non-small cell lung cancer who underwent surgical resection from 2008 to 2013. We established potential site-specific follow-up endpoints when the subsequent recurrence rates fell below 5% and proposed a corresponding follow-up strategy.

Results

With a median follow-up of 111.0 months, postoperative recurrences were observed in 985 patients (41.8 %). We identified several factors associated with site-specific recurrence recurrence patterns, including ground-glass opacity component, sex, histology type, and pathological TNM stage. No recurrence was observed in patients with pure ground-glass nodules, a consolidation-to-tumor ratio less than 0.5, or a pathological type classified as lepidic pattern-predominant adenocarcinoma. In thorax, brain and bone, patients with non-squamous cell carcinoma exhibited higher recurrence rates than those with squamous cell carcinoma. In abdomen and neck, male patients have a higher recurrence rate than female patients, particularly within the pathological stage III group.

Conclusions

The follow-up strategy was developed based on the recurrence patterns analyzed from ten-year follow-up data. The online tool may assist in determining the optimal site-specific duration for surveillance based on clinicopathologic features.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Lung Cancer
Lung Cancer 医学-呼吸系统
CiteScore
9.40
自引率
3.80%
发文量
407
审稿时长
25 days
期刊介绍: Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.
期刊最新文献
MORPHEUS-Lung: biomarkers and clinical response to atezolizumab + bevacizumab + stereotactic body radiotherapy in patients with metastatic non-small cell lung cancer. Development of a clinical prediction model using digital device data for interstitial lung disease in patients with unresectable stage III non-small cell lung cancer treated with durvalumab Epidermal growth factor receptor-targeted near-infrared photoimmunotherapy for malignant pleural mesothelioma Prognostic value of serum CYFRA21-1 in locally advanced non-small cell lung cancer undergoing durvalumab consolidation therapy after chemoradiotherapy Clinical outcomes and tumor immune microenvironment in SMARCA4-Deficient NSCLC: A Real-World retrospective study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1